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Background: Reduced beta2-glycoprotein I (beta2-GPI) is a free thiol-containing form of beta2-GPI that displays a
powerful effect in protecting endothelial cells from oxidative stress-induced cell death. The present study aims to
investigate the effect of beta2-GPI or reduced beta2-GPI on ox-LDL-induced foam cell formation and on cell
apoptosis and to determine the possible mechanisms.
Methods: The RAW264.7 macrophage cell line was selected as the experimental material. Oil red O staining and
cholesterol measurement were used to detect cholesterol accumulation qualitatively and quantitatively,
respectively. Flow cytometry was used to detect cell apoptosis. Real-time quantitative PCR was used to detect the
mRNA expression of the main proteins that are associated with the transport of cholesterol, such as CD36, SRB1,
ABCA1 and ABCG1. Western blot analysis was used to detect the protein expression of certain apoptosis-related
proteins, such as caspase-9, caspase-3, p38 MAPK/p-p38 MAPK and JNK/p-JNK.
Results: Beta2-GPI or reduced beta2-GPI decreased ox-LDL-induced cholesterol accumulation (96.45 ± 8.51 μg/mg
protein vs. 114.35 ± 10.38 μg/mg protein, p < 0.05;74.44 ± 5.27 μg/mg protein vs. 114.35 ± 10.38 μg/mg protein,
p < 0.01) and cell apoptosis (30.00 ± 5.10% vs. 38.70 ± 7.76%, p < 0.05; 20.66 ± 2.50% vs. 38.70 ± 7.76%, p < 0.01), and
there are significant differences between beta2-GPI and reduced beta2-GPI (p < 0.05). Reduced beta2-GPI decreased
the ox-LDL-induced expression of CD36 mRNA and ABCA1 mRNA (p < 0.05), as well as CD36, cleaved caspase-9,
cleaved caspase-3, p-p38 MAPK and p-JNK proteins (p < 0.05 or p < 0.01). Beta2-GPI did not significantly decrease
the expression of ABCA1 mRNA and the p-p38 MAPK protein.
Conclusions: Both beta2-GPI and reduced beta2-GPI inhibit ox-LDL-induced foam cell formation and cell apoptosis,
and the latter exhibits a stronger inhibition effect. Both of these glycoproteins reduce the lipid intake of
macrophages by downregulating CD36 as well as protein expression. Reduced beta2-GPI inhibits cell apoptosis by
reducing the ox-LDL-induced phosphorylation of p38 MAPK and JNK, and the amount of cleaved caspase-3 and
caspase-9. Beta2-GPI does not inhibit the ox-LDL-induced phosphorylation of p38 MAPK.
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Foam cells are the characteristic pathological cells in athero-
sclerotic plaques. The most important reason for foam cell
formation is cholesterol accumulation, particularly ox-LDL
[1]. A variety of proteins are involved in cholesterol* Correspondence: yudemintij@126.com; yupei@tijmu.edu.cn
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reproduction in any medium, provided the oraccumulation. ATP-binding cassette transporter A1
(ABCA1) and G1 (ABCG1) are both important outflow
pathways for lipids in macrophages [2,3]. The scavenger
receptor CD36 is involved in the intake of ox-LDL [4]. In
CD36 knockout mice, the capacities of ox-LDL intake and
foam cell formation were both significantly reduced [5].
Another scavenger receptor, SRB1, mediates the outflow of
cholesterol and inhibits the progress of atherosclerosis [6].
Beta2-glycoprotein I (beta2-GPI) is the main autoantigen
for antiphospholipid syndrome, and its molecular weight istd. This is an open access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited.
Wang et al. Lipids in Health and Disease 2013, 12:174 Page 2 of 9
http://www.lipidworld.com/content/12/1/174approximately 50 kDa, with a circulating concentration of
approximately 4 μmol/L in human plasma [7]. Its physio-
logical function remains unclear. Beta2-GPI is composed of
five complementary control protein modules, named do-
main I to domain V, and domain V contains the binding
site for negatively charged phospholipids [8]. In the crystal
structure of beta2-GPI, a certain disulphide bond is formed
between Cys288 and Cys326 of domain V, which is exposed
on the surface of this protein [8,9]. This disulphide bond
could be opened by thioredoxin-1 (TRX-1), which resulted
in the formation of two free thiols. This form of beta2-GPI
is called reduced beta2-GPI [10,11].
Beta2-GPI is closely associated with atherosclerosis.
George et al. proved the presence of beta2-GPI in athero-
sclerotic plaques [12]. Lin et al. found beta2-GPI could not
only inhibit the translocation of cholesterol from extracellu-
lar pools to macrophages but also prevent NO-induced
apoptosis in vascular cells [13,14]. Reduced beta2-GPI was
recently found to be a protective factor against oxidative
stress-induced endothelial cell death [10], which reminded
us of its potential effect against oxidative stress. Our prelim-
inary experiments indicated that beta2-GPI or reduced
beta2-GPI alone inhibits foam cell formation from U937
human macrophages. The present study aims to investi-
gate the effect of beta2-GPI or reduced beta2-GPI on ox-
LDL-induced foam cell formation and cell apoptosis and
to determine the possible mechanisms of these effects.
Results
Results of Oil red O staining
In the control group, most of the macrophages had no
red lipid droplets, which indicated a low content of the
intracellular lipid. In the ox-LDL group, the macrophages
increased in size and many red lipid droplets could be
clearly observed in the cytoplasm. When beta2-GPI or
reduced beta2-GPI was added, red lipid droplets in
macrophages decreased, and the latter showed a larger
decrease than the former (Figure 1).
Cholesterol content in macrophages
In the ox-LDL group, the contents of TC, FC, CE and the
value of CE/TC were all higher than those contents in the
control group (p < 0.01). The CE/TC value exceeded 50%.
Compared with the ox-LDL group, the TC content of cells
was decreased in both the ox-LDL + beta2-GPI group
and in the ox-LDL + reduced beta2-GPI group (p < 0.05),
whereas reduced beta2-GPI caused a larger decrease than
beta2-GPI (p < 0.05) (Figure 2A,B).
Results of flow cytometry
The total apoptosis rate of macrophages in the blank
control was 11.14 ± 3.15%. After incubation with ox-LDL
(75 μg/mL) for 24 h, the total apoptosis rate of the cells
reached 38.70 ± 7.76%. Beta2-GPI and reduced beta2-GPIsignificantly decreased the total apoptosis rate of the cells
(30.00 ± 5.10% vs. 38.70 ± 7.76%, p < 0.05; 20.66 ± 2.50% vs.
38.70 ± 7.76%, p < 0.01). In addition, there was also a sig-
nificant difference between the two groups (20.66 ± 2.50%
vs. 30.00 ± 5.10%, p < 0.05) (Figure 3).
PCR results
Compared with the control group, the expression of CD36
mRNA and ABCA1 mRNA were both increased in cells
of the ox-LDL group (p < 0.05), whereas the expression of
SRB1 mRNA and ABCG1 mRNA showed no significant
change. Both beta2-GPI and reduced beta2-GPI inhibited
the ox-LDL-induced expression of CD36 mRNA (p < 0.05),
and there was also a significant difference between the
two groups (p < 0.05). Reduced beta2-GPI also inhibited the
ox-LDL-induced expression of ABCA1 mRNA (p < 0.05).
There was no significant difference in the expression
levels of SRB1 mRNA and ABCG1 mRNA in each group
(Figure 4).
Western blot results
Compared with the control group, the expression of CD36,
cleaved caspase-3, cleaved caspase-9, p-p38 MAPK and
p-JNK in macrophages of the ox-LDL group were all
significantly increased (p < 0.01). Both beta2-GPI and
reduced beta2-GPI inhibited the ox-LDL-induced increase
of CD36, cleaved caspase-3, cleaved caspase-9 and p-JNK
(p < 0.01 or p < 0.05), and the latter also inhibited the
expression of p-p38 MAPK (p < 0.01). There was a signifi-
cant difference (p < 0.05) in the expression level of p-p38
MAPK between the two groups (Figure 5A,B).
Discussion
The RAW264.7 cell line was established from the ascites
of a tumour that was induced in a male mouse by the
intraperitoneal injection of Abselon Leukaemia Virus
(ATCC Number: TIB-71). RAW264.7 macrophages are
easy to culture and have strong adhesion and phagocytosis
abilities, which cause its wide use in studies of the pathways
of foam cell formation [15,16]. There are two important
biological characteristics of foam cells. On one hand, the
lipid content in the cytoplasm increases significantly, and
lipids are gathered into droplets, which are primarily ar-
ranged around the inside surface of the cytomembrane;
on the other hand, there is a significant increase in the
content of total intracellular cholesterol, and the choles-
teryl ester content is over 50% of the total intracellular
cholesterol [17]. In the present study, macrophages meet
both typical characteristics of foam cells after incubation
with 75 mg/L of ox-LDL for 24 h.
To determine the concentration of beta2-GPI and
reduced beta2-GPI, we set a concentration gradient
(50, 100, 150, 200 μmmol/L) in the preliminary experiment
and detected the intracellular total cholesterol. Results
Figure 1 Typical pictures of macrophages (Oil red O staining, 320×). RAW264.7 macrophages were seeded onto 96-well microtitre plates at
a density of 2 × 106 cells per well, cultured for 12 h and then serum-starved for another 24 h. Cells were incubated for another 24 h in DMEM,
which was supplemented with ox-LDL alone or along with beta2-GPI or reduced beta2-GPI. Oil red O staining was performed, and macrophages
were observed using an inverted microscope. Ox-LDL increased the formation of red lipid droplets in macrophages and beta2-GPI or reduced
beta2-GPI decreased the formation lipid droplets, while the latter showed a stronger action than the former.
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ited ox-LDL-induced cholesterol influx in a dose-dependent
fashion. Results showed a statistical significance using
the concentration of 100 μmmol/L beta2-GPI or reduced
beta2-GPI. Synthesizes related references [13,14,18,19]
and our preliminary experiment, the concentration of
100 μmmol/L was selected for the mechanism study.
Our study demonstrates for the first time that both
beta2-GPI and reduced beta2-GPI inhibit ox-LDL-induced
foam cell formation and cell apoptosis in vitro, and the lat-
ter demonstrates a stronger inhibition effect. Both of these
glycoproteins reduce the lipid intake of macrophages by
downregulating CD36 mRNA as well as protein expression.
Reduced beta2-GPI inhibits cell apoptosis by reducing the
ox-LDL-induced phosphorylation of p38 MAPK and JNK,
as well as the amount of activated caspase-3 and caspase-9.
Beta2-GPI does not inhibit the ox-LDL-induced phosphor-
ylation of p38 MAPK.
Beta2-GPI could combine with atherosclerosis factors,
such as ox-LDL, CRP and Lp(alpha), to form corresponding
stable complexes [20-23]. Ox-LDL/beta2-GPI complexes
were found in patients that suffer autoimmune diseases
[24], diabetes [25], etc. Autoantibodies further combined
with beta2-GPI in the complexes to form ox-LDL/beta2-
GPI/autoantibody complexes (actually antigen/antibody
complexes), which could be phagocytised by macro-
phages, and actually increased ox-LDL intake and foamcell formation [20,24,26]. However, our study revealed that
beta2-GPI inhibited ox-LDL intake and foam cell formation
in vitro. One possible reason for this result is that there are
no autoantibodies in vitro. Thus, beta2-GPI binds with ox-
LDL; however, the complexes could not be phagocytised by
macrophages. In addition, our study found that beta2-GPI
inhibited the ox-LDL-induced expression of CD36 mRNA.
Both of these reasons contribute to the decrease in ox-LDL
intake and foam cell formation.
Reduced beta2-GPI was first discovered by Ioannou Y
et al. in 2010 [10]. Both beta2-GPI (actually oxidised form)
and reduced beta2-GPI have recently been found in human
serum. Moreover, the proportion of reduced beta2-GPI is
significantly lower in the antiphospholipid syndrome group
than that in healthy individuals [27], which suggests that
reduced beta2-GPI may play a protective role in our bod-
ies. The reduced form of beta2-GPI is generated when the
functional disulphide (Cys288-Cys326) is opened, and
this change results in some functional changes [10,27].
Reduced beta2-GPI was recently found to protect EAhy926
(human vascular endothelial cells) from oxidative stress-
induced endothelial cell damage [15] and to display in-
creased binding to von Willebrand factor (vWF) than
non-reduced beta-GPI in vitro [28].
At present, no studies have reported the correlation
between reduced beta2-GPI and atherosclerosis. Our
study first discovered that reduced beta2-GPI inhibited
Figure 2 Intracellular cholesterol content of RAW264.7
macrophage. (A) The content of intracellular TC, FC and CE.
(B) The ratio of CE to TC. RAW264.7 macrophages were seeded
onto 96-well microtitre plates and then supplemented with
ox-LDL alone or along with beta2-GPI or reduced beta2-GPI.
HPLC-MS method was used to quantitatively determine the
content of free cholesterol. Total protein was detected by the
BCA method, and the final cholesterol content was determined
using the ratio between the cholesterol concentration and the
corresponding protein concentration (μg/mg protein). Ox-LDL
increased the content of TC, FC, CE and the value of CE/TC. Beta2-GPI
or reduced beta2-GPI decreased TC content in macrophages, whereas
latter caused a larger decrease than the former. Note: n = 3, TC, total
cholesterol; FC, free cholesterol; CE, cholesterol ester. *: compared with
the control group, p < 0.01;▲: compared with the ox-LDL group,
p < 0.05;▲▲: compared with the ox-LDL group, p < 0.01; #: compared
with the beta2-GPI group, p < 0.05.
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by inhibiting CD36 expression. However, reduced beta2-
GPI simultaneously inhibited ABCA1 expression, which
is a protein that decreases cholesterol accumulation in
macrophages. Because the net result of these changes isthe reduction of foam cell formation, it is proposed that
there are also other mechanisms in addition to the decrease
of CD36 expression that are responsible for the cholesterol
efflux that is induced by reduced beta2-GPI.
Both macrophages and smooth muscle cells undergo
apoptosis in atherosclerotic plaques [29]. Macrophage
apoptosis promotes the development of the necrotic
core, which is a key factor in rendering plaques vulnerable
to disruption and in acute luminal thrombosis [30]. Both
p38 MAPK and JNK signalling pathways play an important
role in cell apoptosis [31,32]. Caspase-9 and caspase-3 are
key proteins in apoptotic pathways [33]. Our study proved
that reduced beta2-GPI inhibited the ox-LDL-induced
phosphorylation of p38 MAPK and JNK, as well as the
amount of activated caspase-9 and caspase-3, thus inhi-
biting the apoptosis of macrophage-derived foam cells.
Reduced beta2-GPI provides a new direction for the
study of beta2-GPI. Currently, the function of reduced
beta2-GPI has been poorly understood. Further studies
should be performed to investigate this protein’s physio-
logical and pathological roles and to lay the foundation for
further clarify related diseases, such as autoimmune dis-
eases and atherosclerosis, as well as biological processes,
such as coagulation and oxidative stress. Reduced beta2-
GPI may offer a new target for the diagnosis and treatment
of certain diseases in the future.
Conclusions
Both beta2-GPI and reduced beta2-GPI inhibit ox-LDL-
induced foam cell formation and cell apoptosis, and the
latter exhibits a stronger inhibition effect. Both of these
glycoproteins reduce the lipid intake of macrophages by
downregulating CD36 mRNA as well as protein expression.
Reduced beta2-GPI inhibits cell apoptosis by reducing the
ox-LDL-induced phosphorylation of p38 MAPK and JNK,
as well as the amount of cleaved caspase-3 and caspase-9.
Beta2-GPI does not inhibit the ox-LDL-induced phosphor-
ylation of p38 MAPK.
Methods
Materials and regents
The RAW264.7 macrophage cell line was purchased from
the American Type Culture Collection (ATCC number:
TIB-71). Dulbecco’s modified Eagle Medium (DMEM), fetal
bovine serum and ox-LDL were purchased from Beijing
Solarbio Science & Technology Co., Ltd. (Beijing, China).
Oil red O and hematoxylin were purchased from Sigma.
An annexin V-FITC apoptosis detection kit was purchased
from Nanjing KeyGEN Biotech. Co., Ltd. (Nanjing, China).
The TRIzol reagent was purchased from Invitrogen
(Carlsbad, America). A Reverse Transcription Kit and
SYBR ® Premix Ex TaqTM DNA polymerase were pur-
chased from TaKaRa Bio. Inc. (Otsu, Japan). Rabbit anti-
mouse monoclonal antibodies to p38 MAPK, p-p38
Figure 3 Apoptosis rate of macrophages. RAW264.7 macrophages were seeded onto 96-well microtitre plates and then supplemented with
ox-LDL alone or along with beta2-GPI or reduced beta2-GPI. Annexin V-FITC/PI double-labelling and flow cytometry were used to detect the
apoptosis rate of macrophages. Ox-LDL (75 μg/mL) increased the total apoptosis rate of cells. Beta2-GPI and reduced beta2-GPI significantly
decreased the total apoptosis rate of cells, and there was also a significant difference between the two groups. Note: n = 3, *: compared with the
control group, p < 0.01; ▲: compared with the ox-LDL group, p < 0.05; ▲▲: compared with the ox-LDL group, p < 0.01; #: compared with the
beta2-GPI group, p < 0.05.
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Technology, Inc. (Boston, America). Rabbit anti-mouse
monoclonal antibodies to cleaved caspase-3 and cleaved
caspase-9 were purchased from Santa Cruz Biotechnology,
Inc. (Santa Cruz, America). Horseradish peroxidase-labelled
goat anti-rabbit IgG was purchased from Beijing ComWin
Biotech Co., Ltd. (Beijing, China).
Purification of beta2-GPI
Beta2-GPI was purified from normal human plasma by
methods that were described previously [14]. Plasma
beta2-GPI was precipitated by 3% (v/v) perchloric acid
and isolated by heparin-Sepharose affinity chromatography
(HiTrap Heparin, GE Healthcare). LC-MS analysis was
used to confirm this protein. The purity of beta2-GPI was
confirmed by sodium dodecyl sulphate-polyacrylamide gel
electrophoresis (SDS-PAGE) on a 10% mini-gel. The SDS-
PAGE analysis of the protein sample showed an identical
band to that of the standard sample. The BCA method was
used to determine the concentration of beta2-GPI.
Preparation of reduced beta2-GPI
Reduced beta2-GPI was prepared by methods that were
described previously [10]. Purified beta2-GPI (1 μM)
was reduced by TRX-1 (3.5 μM), which was activated
by dithiothreitol (DTT, 70 μM). The thiols of reduced
beta2-GPI were protected by reduced glutathione. The
reduced beta2-GPI was verified using a Western blot
and LC-MS analysis. The Western blot analysis showed
that the new protein maintained the same immunologicalactivity with beta2-GPI. The LC-MS analysis verified that
domain V of the new protein had free thiols.
Cell culture
RAW264.7 cells were cultured in DMEM with 25 mmol/L
glucose, which was supplemented with 10% (v/v) fetal
bovine serum at 37°C in a humidified atmosphere with
5% CO2. Cells were routinely subcultured when grown
to subconfluency (>90% by visual estimate).
Cells were seeded onto 96-well microtitre plates at a
density of 2 × 106 cells per well, cultured for 12 h and
then serum-starved for another 24 h. Four groups were
designed, and cells were incubated for another 24 h in
DMEM, which was supplemented with 25 mmol/L glucose,
10% (v/v) fetal bovine serum and the following interven-
tion factors: (a) blank control; (b) 75 μg/mL ox-LDL; (c)
75 μg/mL ox-LDL + 100 μg/mL beta2-GPI; (d) 75 μg/mL
ox-LDL + 100 μg/mL reduced beta2-GPI.
Oil red O staining
Cell culture was the same as above. Culture medium
was removed, and cells were washed three times with
PBS and fixed in formalin for 30 minutes. Fixed cells
were rinsed with PBS and then with 60% isopropanol
for 5 minutes, and then stained with freshly prepared
Oil Red O working solution for 30 min at 60°C. The
nuclei were lightly stained with haematoxylin for 5 mi-
nutes. Stained cells were rinsed with distilled water,
mounted in glycerine jelly, and then observed using an
inverted microscope.
Figure 4 The expression of CD36, SRB1, ABCA1, and ABCG1 mRNAs in macrophages (compared with control). RAW264.7 macrophages
were seeded onto 96-well microtitre plates and supplemented with ox-LDL alone or along with beta2-GPI or reduced beta2-GPI. Real-time PCR
was used to detect the mRNA levels of CD36, SRB1, ABCA1, and ABCG1. β-actin was selected as the internal control. Ox-LDL increased the
expression of CD36 and ABCA1 mRNAs. Both beta2-GPI and reduced beta2-GPI inhibited the ox-LDL-induced expression of CD36 mRNA, and
there was also a significant difference between the two groups. In addition, reduced beta2-GPI inhibited the ox-LDL-induced expression of ABCA1
mRNA. Note: n = 3, *: compared with the control group, p < 0.01;▲: compared with the ox-LDL group, p < 0.05;▲▲: compared with the ox-LDL
group, p < 0.01; #: compared with the beta2-GPI group, p < 0.05.
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spectrometry (HPLC-MS)
Column: Inertsil ODS column (5 μm, 150 mm×4.6 mm,
purchased from GL Sciences, Tokyo, Japan). Mobile phase:
methanol–water (78:22). Flow rate: mL ·min-1. Temperature:
room temperature. Application volume: 10 μL.
A previous study has described the quantitative deter-
mination of cholesterol by the HPLC-MS method [34].
Based on this method, we made some changes according to
our situation. Cells were washed once with cold PBS and
then sonicated in ice bath for 5 min. The cell lysate was
then subpackaged (200 μL every part). In total, 300 μL of
freshly prepared 15% alcohol-KOH was added to 200 μL of
cell lysate. After 2 hours, 500 μL of hexane:isopropanol so-
lution (4:1, v/v) was added. After 15 min vortex-mixing, the
cell lysate was centrifuged at 4000 rpm for 5 min, and the
upper organic phase was collected. Residual free cholesterolin the lower aqueous phase was extracted twice as described
above. Then, the total clarified supernatants were collected
and evaporated to dryness by vacuum centrifugation. Stig-
masterol was used as an internal standard. A calibration
curve was constructed according to the LC-MS analysis of
solutions that contained stigmasterol (10 μg/mL) and serial
dilutions of cholesterol. Then, the dry sample was dissolved
with a stigmasterol solution (10 μg/mL) and analysed using
the LC-MS method. The total protein in the aqueous phase
was detected by the BCA method, and the final cholesterol
content was determined using the ratio between the choles-
terol concentration and the corresponding protein concen-
tration (μg/mg protein). To detect the total cholesterol
content, cholesterol esterase was used to hydrolyse choles-
terol ester to free cholesterol. The content of cholesterol
ester was equal to the difference between total cholesterol
and free cholesterol.
Figure 5 Relative expression of c-caspase-3, c-caspase-9, p-p38 MAPK, p-JNK and CD36. (A) Typical western blot bands of c-caspase-3,
c-caspase-9, p-p38 MAPK and p-JNK. (B) Relative density of c-caspase-3, c-caspase-9, p-p38 MAPK and p-JNK. (C) Typical western blot bands and
relative density of CD36. RAW264.7 macrophages were seeded onto 96-well microtitre plates and supplemented with ox-LDL alone or along with
beta2-GPI or reduced beta2-GPI. Total protein was measured with a Micro BCATM Protein Assay Reagent Kit. Aliquots of the total protein were
resolved by 4–12% Bis-Tris Gel and blotted onto a nitrocellulose transfer membrane. The membrane was incubated with specific primary
antibodies and then with HRP-anti-rabbit IgG. Radiography was performed using a UVP analytical instrument. β-actin was selected as the internal
control. Ox-LDL increased the expression of c-caspase-3, c-caspase-9, p-p38 MAPK, p-JNK and CD36 in macrophages. Both beta2-GPI and reduced
beta2-GPI inhibited the ox-LDL-induced increase of c-casepase-3, c-casepase-9, p-JNK and CD36, and the latter also inhibited the expression of
p-p38 MAPK. Note: n = 3, *: compared with the control group, p < 0.01;▲: compared with the ox-LDL group, p < 0.05;▲▲: compared with the
ox-LDL group, p < 0.01; #: compared with the beta2-GPI group, p < 0.05.
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Cell culture was the same as above. Cells were digested
with trypsin and collected using centrifugation (2000 rpm,
5 min). 500 μL binding buffer was added to cells. Then
5 μL annexin V-FITC and 5 μL propidium iodide were
added to the binding buffer. Samples were kept in a dark
place for 5–15 mins at room temperature and then flow cy-
tometric analysis was performed. The excitation wavelength
was 488 nm. The emission wavelength was 530 nm.Real-time quantitative PCR
Primers for all tested genes were designed using the Pri-
mer 5.0 software and were evaluated using the Oligo 6.0
software. The primer sequences for CD36 were: forward
5'-GAACCACTGCTTTCAAAAACTGG-3, reverse 5'-
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ABCG1: forward 5'-TTCATCGTCCTGGGCATCTT-3',
reverse 5'-CGGATTTTGTATCTGAGGACGAA-3'; for β-
actin: forward 5'-TGGAGAAGAGCTATGAGCTGCCTG-
3', reverse 5'-GTGCCACCAGACAGCACTGTGTTG-3'.
Total cellular RNA was isolated using the TRIzol reagent
according to the manufacturer’s instructions. Final RNA
concentrations were determined by OD values at 260 nm,
and integrity was verified by ethidium bromide staining
of ribosomal 18S and 28S bands on an agarose gel. The
A260/A280 ratios were from 1.8-2.0. Total RNA was reverse
transcribed into cDNA using a Reverse Transcription Kit.
The PCR reaction system was composed of cDNA, primer,
SYBR Green Mix and ddH2O. PCR cycling conditions were
set as follows: 94°C for 2 min, then 35 cycles at 94°C for
30 sec, 60°C for 30 sec 45, and 72°C for 20 sec. All sample
measurements were performed in triplicate. The relative
quantification was based on β-actin genes to determine
fold-differences in the expression of the target gene.
ΔΔCt-method was used for the normalisation procedure.
The final result was shown by the ratio of 2 –ΔΔCt in the
experimental group to that in the control group.
Western blot
The reaction was terminated by adding 1 mL of cold
PBS, which contained 100 μM sodium vanadate. The
samples were then placed on ice, washed with ice-cold
PBS, and lysed in RIPA lysis buffer for 30 mins. Lysates
were clarified by centrifugation at 12000 rpm for 15 min
at 4°C, and the protein content in the supernatant was
measured with a Micro BCATM Protein Assay Reagent
Kit according to the manufacturer’s instructions. Aliquots
(30 μg protein per lane) of the total protein were resolved
by NuPAGETM 4–12% Bis-Tris Gel and blotted onto a
nitrocellulose transfer membrane. The membrane was
blocked with 2% BSA in TBST (20 mM Tris–HCl,
pH 7.6, 137 mM NaCl and 0.01% Tween-20) for 1 h at
RT, followed by incubation with specific primary anti-
bodies (to CD36, p38 MAPK, p-p38 MAPK, JNK and
p-JNK, cleaved caspase-3 and cleaved caspase-9). After
washing with TBST, the membrane was reprobed with
HRP-anti-rabbit IgG (1:1000) in 2% BSA in TBST for
60 min at RT. Radiography was performed using a
UVP analytical instrument. β-actin was selected as the
internal standard protein.
Statistical analysis
The data are expressed as the mean ± SEM. Differences
between two groups were analysed using Student’s t-test,
and differences between multi-groups were analysed
using a one-way analysis of variance. When statistically
significant differences were found, individual compari-
sons were made using Tukey’s test. Significance was
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